Mon.Jun 01, 2020

article thumbnail

COVID-19 Clinical Trial Updates

My Local Study

“There are decades where nothing happens, and there are weeks where decades happen.” Each day that passes us, there’s new information released about COVID-19 and humanity’s efforts to tackle this global pandemic. The constant updates are enough to make your head spin; so, here’s what you need to know right now. What’s New With COVID-19?

article thumbnail

Visit Asembia’s Specialty Pharmacy Summit Virtual Experience

Drug Channels

Like many of you, I was disappointed that Asembia had to cancel its 2020 Specialty Pharmacy Summit. As a small consolation, Asembia is providing a series of on-demand business sessions. You can view them for FREE if your registration to the 2020 Specialty Pharmacy Summit was transferred to the 2021 Summit. Everyone else will have to pay a small fee.

article thumbnail

Two PM(NOC) Actions Dismissed After Common Trial on Validity of Treatment Regimen Patent

Pharma in Brief

The Federal Court has dismissed two infringement actions brought against defendants under subsection 6(1) of the Patented Medicines (Notice of Compliance) Regulations ( Regulations ), following a common trial on the validity of Canadian Patent No. 2,562,277 ( 277 Patent ). The Court found that all the asserted claims – to uses for treating multiple sclerosis ( MS ) – were obvious and that some were anticipated.

Trials 40